Triple-negative breast cancer cells produce inflammatory cytokines
Interleukin-6 (IL-6) and Interleukin-8 (IL-8), which in turn stimulate
the growth of cancer cells, according to a study published in the June
issue of Cancer Research, a publication of the American Association
for Cancer Research.
The study identified new targeted therapies for patients with
triple-negative breast cancer focused on signaling molecules called cytokines...